Search

everythinglearnresearchcommunity

for

Search:↓

Personalized skincare can be improved by understanding genetic differences and using compounds like Resveratrol and Quercetin.

The new method can measure sleep-related hormones in hair effectively and could help track long-term sleep patterns.

Neurospectrum effectively analyzes neural signals to predict and identify brain activity patterns better than traditional methods.

Proteomics combined with other technologies can lead to a better understanding of skin diseases.

Personalized skin rejuvenation using genomics shows promise but needs more research.

Lung microbiome research is growing, focusing more on specific mechanisms and clinical uses.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

Extracellular vesicles can help treat skin issues like wounds, hair loss, aging, and inflammation.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Prostate cancer is common, but risk can be reduced by avoiding smoking, unhealthy diet, inactivity, certain medications, and risky jobs.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Blood hormone levels don't accurately show brain hormone levels in males.

Lower Gas6 and sAxl levels are linked to hair loss in COVID-19 survivors.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Rational design strategies are crucial for developing effective nanozymes for anti-inflammatory uses.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Addressing biological changes in lipids, metabolism, and microbiota may help treat hair loss in young Chinese females with oily scalps.

Advancements in liver cirrhosis treatment and prognosis could improve patient care.

A comprehensive system is needed to ensure cosmetics are safe and effective, using global insights and new AI technologies.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Hair glucocorticoid levels and gut bacteria are linked to growth rates in piglets.